The effects of STAT1 dysfunction on the gut
- 1 March 2016
- journal article
- Published by LymphoSign Journal Limited Partnership in LymphoSign Journal
- Vol. 3 (1) , 19-33
Abstract
Introduction: Mutations in the signal transducer and activator of transcription1 (STAT1) have been associated with a variety of clinical patterns. Interestingly patients with heterozygous mutations in the DNA binding domain (DBD) of STAT1 suffer acute and chronic colitis. Methods: To further analyze the role of STAT1 deficiency in intestinal inflammation, we employed protein expression analysis of total and activated STAT1 in intestinal biopsy samples from 2 patients with heterozygous mutations in the DBD of the STAT1 gene. Results: Both patients showed clinical and histological features of colitis. Total and activated STAT1 were decreased in duodenal and colonic enterocytes, and total STAT1 was found to be mislocalized in aggregates subapically. In addition, intestinal biopsy samples showed decreased numbers of lymphocytes. Patient-derived lymphoblasts demonstrated lack of viability and high susceptibility for cell death. Conclusion: STAT1 expression and distribution in the gut of patients with mutations in the DBD are abnormal, suggesting a primary role of STAT1 dysfunction in enterocytes in addition to the secondary effect of aberrant inflammation. Statement of novelty: Colitis associated with STAT1 mutations appears to have unique features distinct from typical inflammatory bowel disease.Keywords
This publication has 24 references indexed in Scilit:
- Molecular mechanisms of mucocutaneous immunity against Candida and Staphylococcus speciesJournal of Allergy and Clinical Immunology, 2012
- Defining combined immunodeficiencyJournal of Allergy and Clinical Immunology, 2012
- STAT1Mutations in Autosomal Dominant Chronic Mucocutaneous CandidiasisNew England Journal of Medicine, 2011
- STAT1 and pathogens, not a friendly relationshipBiochimie, 2010
- A partial form of recessive STAT1 deficiency in humansJournal of Clinical Investigation, 2009
- PARP inhibition versus PARP-1 silencing: different outcomes in terms of single-strand break repair and radiation susceptibilityNucleic Acids Research, 2008
- Novel STAT1 Alleles in Otherwise Healthy Patients with Mycobacterial DiseasePLOS Genetics, 2006
- Impaired response to interferon-α/β and lethal viral disease in human STAT1 deficiencyNature Genetics, 2003
- Inflammatory Bowel DiseaseNew England Journal of Medicine, 2002
- Impairment of Mycobacterial But Not Viral Immunity by a Germline Human STAT1 MutationScience, 2001